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Ethnopharmacological relevance: Jinlida granule (JLDG), composed of seventeen Chinese medical herbs, is
a widely used Chinese herbal prescription for treating diabetes mellitus. However, the mechanism
underlying this effect remains unclear. To determine the main components in JLDG and to explore the
effect of JLDG on autophagy and lipid accumulation in NIT-1 pancreatic β cells exposed to politic acid (PA)
through AMP activated protein kinase (AMPK) signaling pathway.
Materials and methods: JLDG was prepared and the main components contained in the granules were
identiﬁed by ultra performance liquid chromatography (UPLC) ﬁngerprint. Intracellular lipid accumulation in
NIT-1 cells was induced by culturing with medium containing PA. Intracellular lipid droplets were observed
by Oil Red O staining and triglyceride (TG) content was measured by colorimetric assay. The formation of
autophagosomes was observed under transmission electron microscope. The expression of AMPK and
phospho-AMPK (pAMPK) proteins as well as its downstream fatty acid metabolism-related proteins (fatty
acid synthase, FAS; acetyl-coA carboxylase, ACC; carnitine acyltransferase 1, CPT-1) and autophagy-related
genes (mammal target of rapamycin, mTOR; tuberous sclerosis complex 1, TSC1; microtubule-associated
protein 1 light chain 3, LC3-II) were determined by Western blot. The expression of sterol regulating element
binding protein 1c (SREBP-1c) mRNA was examined by real time PCR (RT-PCR).
Results: Our data showed that JLDG could signiﬁcantly reduce PA-induced intracellular lipid accumulation in
NIT-1 pancreatic β cells. This effect was associated with increased protein expression of pAMPK and AMPK in
NIT-1 cells. Treatment with JLDG also decreased the expression of AMPK downstream lipogenic genes
(SREBP-1c mRNA, FAS and ACC proteins) whereas increased the expression of fatty acid oxidation gene (CPT-
1 protein). Additionally, JLDG-treated cells displayed a markedly increase in the number of autophagosomes
which was accompanied by the down-regulation of mTOR and the up-regulation of TSC1 and LC3-II proteins
expression. However, when AMPK phosphorylation was inhibited by Compound C, JLDG supplementation
did not exhibit any effect on the expression of these AMPK downstream molecules in NIT-1 cells.
Conclusions: The results suggest that JLDG could reduce intracellular lipid accumulation and enhance the
autophagy in NIT-1 pancreatic β cells cultured with PA. The mechanism is possibly mediated by AMPK
activation.
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1. Introduction
The prevalence of diabetes mellitus (DM) has continued to
increase globally, especially in China. According to the latest report,
the prevalence of diabetes was estimated to be 11.6%, representing a
total of 113.9 million Chinese adults with diabetes (Xu et al., 2013).
Type 2 diabetes mellitus (T2DM) is the most common form which
accounts for 90–95% of those with diabetes. In the onset and
progression of T2DM, β cell dysfunction caused by elevated levels
of glucose and/or free fatty acids (FFAs) play an important role
(Marchetti et al., 2010). Chronic exposure to FFAs leads to lipid
overload of β cells, impaired insulin secretion and apoptotic cell
death (Zhou and Grill, 1994; Shimabukuro et al., 1998; Piro et al.,
2002). Therefore the strategy for protecting pancreatic β cells against
lipid overload may have a potential for the prevention and treatment
of diabetes.
Autophagy is a lysosomal degradative pathway that protects cells
from death under stressful conditions. This process consists of
several sequential steps—sequestration, transport to the lysosome,
degradation, and utilization of degradation products (Mizushima,
2007). Through the autophagic process, damaged organelles and
proteins are degraded or recycled, which is shown as an adaptive
pro-survival response (Ryter and Choi, 2013). Recently, intracellular
lipid droplets (LDs) have been also identiﬁed as the substrate for
autophagy. Autophagy mobilizes lipids from LDs for metabolism
through a process termed lipophagy, thereby preventing intracellu-
lar lipid overload (Singh et al., 2009; Dong and Czaja, 2011).
Defective autophagy has been found to be related to lipid metabolic
disorders such as fatty liver and obesity (Singh and Cuervo, 2012).
Furthermore, when autophagy is impaired, the architecture and
function of beta-cells could not be maintained (Fujitani et al., 2009).
However, the relation between autophagy and lipid metabolism in
pancreatic β cells under the condition of lipid overload has been
rarely reported.
DM is referred to as “Xiao Ke” disease in Traditional Chinese
Medicine (TCM). “Xiao” means emaciation and “Ke” means thirst.
But these two typical symptoms may not be obvious in patients
with diabetes. Conversely, some patients have no symptoms
except for obesity, which is a condition of excess body fat.
According to the theory of TCM, excess body fat is described as
excess phlegm and moisture caused by deﬁciency of spleen. Thus,
tonifying spleen may serve as an effective measure against phlegm
and moisture overload, thereby protecting cells from lipotoxicity.
Jinlida granule (JLDG) is a widely used Chinese herbal prescription
for tonifying spleen. It contains seventeen herbs including Radix
Ginseng (Panax ginseng C.A.Mey.), Rhizoma Polygonati (Polygonatum
kingianum Coll. et Hemal.), Rhizoma Atractylodis (Atractylodes
lancea (Thunb.) DC.), Radix Sophorae Flavescentis (Sophora ﬂaves-
cens Ait.), Radix Ophiopogonis (Ophiopogon japonicus (Thunb.) Ker-
Gawl.), Radix Rehmanniae (Rehmannia glutinosa Libosch.), Radix
Polygoni Multiﬂori (Polygonum multiﬂorum Thunb.), Fructus Corni
(Cornus ofﬁcinalis Sieb. et Zucc.), Poria (Poria cocos (Schw.) Wolf.),
Herba Eupatorii (Eupatorium fortunei Turcz.), Rhizoma Coptidis
(Coptis chinensis Franch.), Rhizoma Anemarrhenae (Anemarrhena
asphodeloides Bge.), Herba Epimedii (Epimedium brevicornum
Maxim.), Radix Salviae Miltiorrhizae (Salvia miltiorrhiza Bge.), Radix
Puerariae (Pueraria lobata (Willd.) Ohwi.), Semen Litchi (Litchi
chinensis Sonn.) and Cortex Lycii (Lycium chinense Mill.). In modern
Chinese medicine practice, JLDG is widely used to treat diabetes
mellitus. Clinical trials have also demonstrated that homeostasis
model assessment of β-cell function (HOMA-β) score is improved
after oral intake of JLDG in diabetic patients (Gao et al., 2010; Yu
and Yang, 2013). However, the mechanism underlying this protec-
tion of β-cells remains unclear. Recently, few researches have
showed that JLDG exerted good protection of β-cells as well
as other organs through multi-target activity in diabetic rats
(Shi et al., 2012; Wu et al., 2012; Li and Zhao, 2013). In the present
study, we investigated the effect of JLDG on palmitic acid (PA)-
induced lipid accumulation and autophagy in NIT-1 pancreatic
β cells.
2. Material and methods
2.1. Herbal materials and the preparation of JLDG
JLDG was supplied by Yiling Pharmaceutical Co. Ltd. (Shijiaz-
huang, Hebei, China). Seventeen kinds of herbs contained in JLDG
were all purchased from Meiwei Traditional Chinese Medicine
Company in Hebei Province (Anguo, China). The voucher specimen
was deposited at the herbarium of the Pharmacy Faculty at the
Beijing University of Chinese Medicine and authenticated by the
Department of Pharmacognocy, Beijing University of Chinese
Medicine (Beijing, China). Seventeen herbs were crashed into
crude grains and extracted by reﬂuxing with boiling water. Then
the solution obtained was subsided by ethanol and the extract was
concentrated and vacuum-dried to granules. Finally, per gram dry
granule obtained is equivalent to 6.69 g raw medical herbs. For the
present experiment, suspension solution of the granules was made
in 0.5% of carboxymethyl cellulose solution before use.
2.2. Chemicals and reagents
Bovine serum albumin (BSA), palmitate (PA) and rapamycin (Rapa)
were obtained from Sigma-Aldrich Co. (St. Louis, MO, USA). Pioglita-
zone (PIO) hydrochloride tablets were purchased from Takeda Phar-
maceutical Co. Ltd. (Osaka, Japan). 5-Aminoimidazole-4-carboxamide
1-β-D-ribofuranoside (AICAR) and Compound C were obtained from
Sigma-Aldrich Co. (St. Louis, MO, USA). Roswell Park Memorial
Institute-1640 (RPMI-1640) and fetal bovine serum (FBS) were
obtained from Hyclone Laboratories Inc. (Logan, UT, USA). Penicillin,
streptomycin, trypsin and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide (MTT) assay kit were obtained from Guge
biological Technology Co. (Wuhan, Hubei, China). Triglyceride colori-
metric assay kit was purchased from Shanghai Mind Bioengineering
Co, Ltd (Shanghai, China). Bicinchoninic acid (BCA) protein assay kit
and enhanced chemiluminescence (ECL) reagent were obtained from
Beyotime Institute of Biotechnology (Shanghai, China). Rabbit anti-
mouse fatty acid synthase (FAS), AMP activated protein kinase
(AMPK), acetyl-coA carboxylase (ACC) and carnitine acyl transferase
1 (CPT-1) antibodies were from Abcam Company (Hongkong, China).
Rabbit anti-mouse phospho-AMP activated protein kinase (pAMPK)
was obtained from Millipore Corporation (Billerica, MA, USA). Rabbit
anti-mouse mammal target of rapamycin (mTOR), microtubule-
associated protein 1 light chain 3 (LC3-II) and tuberous sclerosis
complex 1 (TSC1) were provided by Santa Cruz Biotechnology (Santa
Cruz, CA, USA). Trizol reagent, PrimeScript RT reagent Kit and SYBR
Premix Ex Taq were purchased from TaKaRa Bio Inc. (Dalian, Liaoning,
China).
2.3. Preparation of JLDG-containing serum
The rat dose of JLDG was obtained by the conversion of the human
dose to rat equivalent dose based on body surface areas. Male SD rats
(200–250 g) were obtained from SLAC Laboratory Animal Co., Ltd.
(Shanghai, China). Rats were housed under speciﬁc pathogen-free
conditions and fed a standard rodent laboratory diet from SLAC
Laboratory Animal Co., Ltd for two weeks. Then rats were randomly
divided into four groups. Rats in the three JLDG groups were orally
administrated low (0.75 g/kg), intermediate (1.5 g/kg) and high
(3.0 g/kg) doses of JLDG, respectively. Rats in PIO-treated group were
orally administrated PIO (25mg/kg). The corresponding therapy was
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administered twice a day for three days. After 1 h of the last intragastric
administration, all rats were anesthetized by intraperitoneal injection
of sodium pentobarbital and gathered blood through abdominal aorta
under sterile condition. Serum obtained was then sterilized by ﬁltering
through a 0.22mm ﬁlter and stored at 20 1C till needed for use. All
procedures involving animals complied with the Institutional Animal
Care and Use Committees of Huazhong University of science and
technology.
2.4. Determinations of the main chemical constituents in JLDG by
UPLC analysis
Ultra performance liquid chromatography (UPLC) ﬁngerprint
was performed to identify the main chemical constituents in JLDG
(Jiang et al., 2013). Tanshinol sodium, puerarin, salvianolic acid B,
epimendin B, epimendin C, icariin, ginsenoside Rb1, ginsenoside
Rc, ginsenoside Rb2, purchased from National Institutes for Food
and Drug Control (Beijing, China), were taken as reference stan-
dards. UPLC was performed on a Acquity UPLC system (Waters
Corporation, Milford, MA, USA) equipped with an Acquity BEH C18
column (2.1 mm100 mm, 1.7 μm). The mobile phase included
acetonitrile (B) and 0.1% phosphate (D) at a ﬂow speed of
0.3 ml/min in the condition of column temperature 40 1C. The
gradient elution was as follows: 0–1 min, 4–4%B, 1–3 min, 4–7.5%B,
3–12 min, 7.5–17%B, 12–13 min, 17–20%B, 13–20 min, 20–32%B,
20–21 min, 32–40%B, 21–25 min, 40–56%B, 25–29 min, 56–90%B,
29–35 min, 90–90%B. There were ten batches of JLDG supplied by
Yiling Pharmaceutical Co. Ltd to detect the similarity. The similar-
ity of ﬁngerprints was analyzed by professional software named
Similarity Evaluation System for Chromatogram Fingerprint of
Traditional Chinese Medicine (version of 2004A).
2.5. Cell culture, viability assay and intervention
The mouse NIT-1 pancreatic β cells were provided by Department
of Immunology, Tongji Medical College, Huazhong University of
Science and Technology. The cells were cultured in RPMI-1640
medium supplemented with 10% FBS, 100 units/ml penicillin and
100 units/ml streptomycin and maintained at 37 1C in a humidiﬁed
atmosphere of 5% CO2 and 95% air. Mediums containing different
types of rat serum (10% low dose JLDG serum, 10% intermediate dose
JLDG serum,10% high dose JLDG serum,10% PIO serum) were prepared
to identify cytotoxicity by MTT assay.
NIT-1 cells were seeded at 5103 cells per well in 96 well-culture
plates. After cells have adhered, the medium was replaced by serum
containing different dugs. The cell viability in the serum containing
different concentration of drugs was evaluated byMTTassay according
to manufacturer’s protocol. Under the conditions of this study, 10%
intermediate dose JLDG serum and 10% PIO serum had negligible
effect on cell viability (data not shown).
Approximately, 1105/ml cells were transferred into two 6-well
plates and allowed to grow overnight to 70% conﬂuence. Then all
types of culture mediums were respectively replaced according to the
different cell groups as follows. The culture medium in control group
contained 10% FBS. The medium in model group contained PA
(0.25 mmol/l) and 0.5% BSA. The mediums in different treatment
groups as below also contained PA(0.25 mmol/l), respectively. Further-
more, the medium in JLDG group contained 10% intermediate
dose JLDG serum. The medium in AICAR group contained AICAR
(0.5 mmol/l) and 0.5% BSA. The medium in Compound C group
contained 10% intermediate dose JLDG and Compound C (10 μmol/l).
The medium in PIO group contained 10% PIO serum. For the detection
of autophagy-related molecules, a RAPA group was also set up and the
medium contained Rapa (50 nmol/l) and 0.5% BSA.
2.6. Measurement of intracellular triglyceride content and oil red O
staining
The content of intracellular TG was measured by a determiner TG
kit using colorimetric assay and expressed as micrograms of lipid per
milligrams of cell protein (Yang et al., 2012). Oil red O staining was
applied to determine the accumulation of lipid as previously described
(Lee et al., 2004). Brieﬂy, NIT-1 cells were seeded in 6-well plates at a
density of 1105 cells/well and cultured for 24 h in the presence of
PA (0.25 mmol/l). For different treatment groups, the medium also
contained corresponding drugs. At the end of the culture, the cells
were rinsed with PBS twice and ﬁxed with 10% formalin for half an
hour. After twice washing with PBS again, the cells were stained with
oil red O for 15 min at room temperature, followed by decolorization
with 60% isopropanol. Then the lipid droplets in the cells were
observed and the photos were captured under a light microscope
(TE2000-E, Nikon).
2.7. Transmission electron microscope
The autophagy of NIT-1 cells was evaluated by autophagosome
screening under transmission electron microscope (FEI Tecnai G212,
Netherlands). At the end of intervention, the cells were digested with
0.25% trypsin and collected in centrifuge tubes. Then the cells were
centrifuged at 1500 r/min for 10 min, followed by another centrifuga-
tion at a speed of 800 r/min for the same time. The supernatant was
discarded and 2.5% glutaraldehyde was added into the tube to ﬁx the
cells. After 15 min of ﬁxation, dehydration, embedding, sectioning and
staining was performed under general supervision. Then the autop-
hagosomes were observed under a transmission electron microscope
and photographed.
2.8. Western blot analysis
Cells in each group were lysed with RIPA lysis buffer for extracting
cell total protein. The lysates were centrifuged at 12,000 g for 10min
at 4 1C. Then the supernatants were assayed for protein concentration
using the BCA method. After solubilized in sodium dodecyl sulfate
polyacrylamide gels (SDS-PAGE) sample buffer and heated in boiling
water for 10min, 100 μg protein was separated on 10% SDS-PAGE and
transferred onto nitrocellulose (NC) membranes. Then the membranes
were blocked with 5% skimmed milk powder in TBST for 1 h, followed
by incubationwith primary antibodies (ACC, FAS, AMPK, pAMPK, CPT-1,
mTOR, TSC1, LC3-II) for 2 h at room temperature and overnight at 4 1C.
Wash the membranes with PBST three times for 10min each and
incubate the membranes with horseradish peroxidase (HRP) conju-
gated secondary antibodies. After another three washes, the mem-
branes were detected by enhanced chemiluminescence (ECL) Western
Blot Detection Kit. Finally, the membranes were exposed to imag-
ing ﬁlm and quantiﬁed using KODAK Digital Imaging System
(KODAK, USA).
2.9. RNA extraction and real-time PCR
Total RNA from cells in different groups were extracted with Trizol
reagent. The purity and concentration of total RNAwere measured by a
Nucleic Acid/Protein Analyzer (Thermo, Rockford, USA). Then 2 μg
of total RNA was reverse-transcribed using a PrimeScript RT reagent
Kit in a total reaction volume of 20 μl. cDNA was synthesized in a
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Mastercycler gradient PCR apparatus (Eppendorf Company, Hamburg,
Germany). Then 2.0 μl of cDNA was ampliﬁed in a 20 μl PCR reaction
containing 6.8 μl ddH2O, 0.4 μl forward primer, 0.4 μl reverse primer,
0.4 μl ROX Reference Dye (50 ) and 10.0 μl SYBR premix EX TaqTM
(TaKaRa Company, Dalian, China) with an Applied Biosystems StepOne
Real-Time PCR System (StepOne, Foster City, USA). The reaction
Fig. 1. UPLC ﬁngerprints of Jinlida granule from ten batches.
Fig. 2. UPLC ﬁngerprint of JLDG (a) and reference standards (b). Peak number and identity: 4: tanshinol; 17: puerarin; 34: salvianolic acid B; 37: epimendin B; 38: epimendin
C; 39: icariin; 41: ginsenoside Rb1; 42: ginsenoside Rc; 44: ginsenoside Rb2.
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included stage1, 95 1C for 30 s; stage2, 95 1C for 5 s; stage 3, 60 1C for
30 s. The primer sequences were as follows: SREBP-1c: forward, 50-
CCGAGATGTGCGAACTGGA-30, reverse, 50-GAAGTCACTGTCTTGGTTGTT-
GATG-30; β-actin: forward, 50-CATCCGTAAAGACCTCTATGCCAAC-30,
reverse, 50-ATGGAGCCACCGATCCACA-30. 2ΔΔCT was used to calculate
the relative fold-changes of each group.
2.10. Statistical analysis
All results were presented as mean7standard deviation (SD)
and analyzed using SPSS 19.0 software. One-way analysis of
variance (ANOVA) was used to determine the statistical signiﬁ-
cance. Based on data assumed equal variances or not assumed
equal variances, a LSD or Dunnett’s T3 test was used, respectively.
Meanwhile, descriptive and variance homogeneity test were also
followed. Po0.05 was considered statistically signiﬁcant.
3. Results
3.1. UPLC proﬁle of JLDG
UPLC ﬁngerprint of JLDG from ten batches was shown in Fig. 1.
The result showed that the similarity index of ten batches was up
to 0.99 (data not shown). Fifty common peaks were detected
(Fig. 2a) and nine of them were identiﬁed by comparing the
retention time and peak height with reference standard (Fig. 2b).
The main constituent of JLDG were as follows: tanshinol, puerarin,
salvianolic acid B, epimendin B, epimendin C, icariin, ginsenoside
Rb1, ginsenoside Rc and ginsenoside Rb2.
3.2. The effect of JLDG decreased intracellular lipid accumulation in
NIT-1 cells
To determine the effect of JLDG on lipid accumulation in NIT-1
cells, Oil Red O staining and methods of colorimetric assay were
used. As shown in Fig. 3, intracellular lipid droplets in JLDG group
were signiﬁcantly decreased compared with those in model group.
Meanwhile, intracellular TG content was also remarkably reduced
(Po0.05) in the cells of JLDG group (Fig. 4). This reduction of
intracellular lipid accumulation was also found after the interven-
tion with AICAR (Po0.05), which are known activators of AMPK.
However, the AMPK inhibitor Compound C blocked the effect of
JLDG on decreasing PA-induced intracellular lipid accumulation in
NIT-1 cells (Po0.05).
3.3. The effect of JLDG on the expressions of AMPK and its
downstream fatty acid metabolism-related genes in NIT-1 pancreatic
β cells
Since AMPK activation requires phosphorylation of threonine
residue (T172) in the catalytic α subunit (Bright et al., 2009), we
examined the protein expression of pAMPK and AMPK in NIT-1 cells.
As shown in Fig. 5A and B, in our study, treatment with JLDG
exhibited a signiﬁcant increase in the protein expression of pAMPK
and AMPK compared with the model group (Po0.01). With regard
to the ratio of pAMPK to AMPK (Fig. 5C), it also presented a fold
change (Po0.01) of at least 1.5, indicating a signiﬁcant activation of
AMPK after JLDG supplementation. Consistent with AMPK activa-
tion, the expression of AMPK downstream lipogenic genes (SREBP-
1c mRNA, FAS and ACC proteins) was reduced (Po0.05; Po0.01)
whereas the expression of fatty acid oxidation gene (CPT-1 protein)
Fig. 3. The effect of JLDG on PA-induced lipid accumulation in NIT-1 pancreatic β cells. Staining of lipid droplets with Oil Red O showed that PA caused an apparent increase
in intracellular lipid accumulation, which was attenuated by the treatment with JLDG.
Fig. 4. The effect of JLDG on intracellular TG content of NIT-1 pancreatic β cells
exposed to PA. JLDG supplementation decreased intracellular TG content in NIT-1
pancreatic β cells. *Po0.05, signiﬁcantly different from control. ΔPo0.05, signiﬁ-
cantly different from model group. #Po0.05, signiﬁcantly different from JLDG
group. Each bar represents means7SD from three wells.
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Fig. 5. The effect of JLDG on the expressions of AMPK and its downstream fatty acid metabolism-related genes in NIT-1 pancreatic β cells. JLDG supplementation inhibited
the expression of lipogenic genes and enhanced the expression of fatty-acid oxidase gene through AMPK activation. Representative gels and protein levels for AMPK (A),
pAMPK (B), FAS (D), ACC (E) and CPT-1 (F) measured by Western blot in NIT-1 pancreatic β cells. pAMPK/AMPK ratio (C) and SREBP-1c (G) mRNA levels in NIT-1 cells from
control, model, JLDG, AICAR, Compound C and PIO groups. Each bar represents means7SD from three wells. nPo0.05 and nnPo0.01, signiﬁcantly different from control.
ΔPo0.05 and ΔΔPo0.01, signiﬁcantly different from model group. #Po0.05 and ##Po0.01, signiﬁcantly different from JLDG group.
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was enhanced (Po0.01) (Fig. 5D to G). However, when AMPK
phosphorylation was inhibited by Compound C, JLDG administration
did not exhibit any effect on the expression of these AMPK down-
stream molecules in NIT-1 cells (Po0.05; Po0.01). These ﬁndings
indicate that the effect of JLDG on decreasing intracellular TG
content may be due to the activation of AMPK.
3.4. The effect of JLDG on PA-induced autophagy and the expression
of autophagy-related genes in NIT-1 pancreatic β cells
To verify if enhanced autophagy is involved in the effect of JLD on
PA-induced lipid accumulation in NIT-1 cells, the formation of
autophagosomes was observed and the expression of autophagy-
related genes were examined. As shown in Fig. 6, PA supplementation
increased the number of intracellular autophagosomes in NIT-1 cells of
model group, accompanied by over-expression (Po0.01) of LC3-
IIproteins (Fig. 7C), a well-known marker of autophagy. It may serves
as an adaptive response under conditions of lipid overload. The cellular
autophagy inducer Rapa also markedly enhanced the autophagic
vacuoles formation in NIT-1 cells. Compared with the model group,
JLDG-treated cells exhibited an obvious increase in the number of
intracellular autophagosomes. This increase was associated with decr-
eased expression of mTOR protein (Po0.05) (Fig. 7A) and increased
expression of TSC1 and LC3-IIproteins (Po0.05; Po0.01) (Fig. 7B and
C). Similar results were also obtained when cells were cultured with
AMPK activators (PIO and AICAR) and autophagy inducer (Rapa)
(Po0.01). However, supplementation with AMPK inhibitor, Com-
pound C blocked the enhancing effect of JLDG on the autophagy in
NIT-1 β cells (Po0.01). Together, these results suggest that JLDG may
enhance PA-induced autophagy in β cells via AMPK activation.
4. Discussion
JLDG is a Chinese herbal prescription widely used to treat diabetes
mellitus in the clinical practice of traditional Chinese medicine.
However, the mechanism underlying its anti-hyperglycemic effect is
still unknown. In the present study, by using serum pharmacology, we
found that JLDG could enhance the autophagy and reduce fat deposi-
tion in pancreatic β cells exposed to elevated concentration of FFAs.
We also found that both of these actions were inhibited by Compound
C, an AMPK inhibitor. Since increased autophagy is considered as a
protective mechanism against fatty acid-induced lipotoxicity (Mei
et al., 2011), we suppose that the anti-diabetic effect of JLDG might
be associated with its protection of pancreatic β cells via AMPK
activation.
In type 2 diabetes mellitus, a progressive decline of β-cell function
and mass is a common feature of the disease (Fonseca, 2009). It has
been demonstrated that many factors are related to the reduction of β
cell function and mass such as hyperglycemia, elevated FFAs, islet
amyloid, cytokines and insulin resistance (Cernea and Dobreanu,
2013). Among these, FFAs have attracted much attention (Shao et al.,
2013). Generally, β cells undergo metabolic adaptations including lipid
accumulation and insulin release under conditions of high FFAs levels
(Vernier et al., 2012). However, when lipid inﬂux exceeds its capacity
for lipid storage, lipotoxicity may occur. Elevated FFAs may trigger
endoplasmic reticulum (ER) stress followed by the activation of
autophagy (Kharroubi et al., 2004; Ogata et al., 2006). Ultrastructural
study has also proved that the exposition of β cells to PA, but not to
high glucose, is associated with the formation of lipid droplets and
autophagolysomes, together with enlarged and prevalently perinuc-
lear cysternae, indicating a remarkable ER stress (Martino et al., 2012).
Here, activated autophagy has been proposed as a cell survival
Fig. 6. The effect of JLDG on the number of intracellular autophagosomes in NIT-1 pancreatic β cells. JLDG supplementation enhanced the formation of intracellular
autophagosomes in NIT-1 cells. Representative transmission electron microscope images from control, model, JLDG, AICAR, Compound C, PIO and Rapa groups. (Arrows are
pointing at intracellular autophagosomes).
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response to lipid overload. On one side, stimulation of autophagy
could reduce ER stress associated with the attenuation of apoptosis in
β cells (Bachar-Wikstrom et al., 2013). On the other side, autophagy
could degrade lipid droplets through a process termed lipophagy
(Dong and Czaja, 2011). Thus, activation of autophagy may become a
new therapeutic approach for maintenance of normal β cell function
and survival.
AMPK is known to be a key regulator of cellular lipid metabolism
(Hardie, 2008), and is considered as a positive regulator that stimulates
autophagy in response to lipid overload. Moreover, AMPK is a nutrient
and energy sensor that maintains cellular energy homeostasis (Hardie
et al., 2012). The inhibition of AMPK is always associated with the
development of fat deposition disorders such as obesity and diabetes.
It has been long recognized that AMPK activation could regulate lipid
metabolism by stimulating fatty acid oxidation and inhibiting lipogen-
esis (Hardie, 2004; O’Neill et al., 2013). Therefore the antilipotoxic
effect of AMPK activation represents a new therapeutic target for the
treatment of obesity and type 2 diabetes. Until now, numerous AMPK
activators have been reported. Natural activator (e.g. berberine,
resveratrol and capsaicin) and chemical synthesis activator (e.g. AICAR,
PIO and metformin) have been proved to be involved in lipid meta-
bolism (Srivastava et al., 2012). However, their effect in the regulation
of autophagy has been poorly reported. In the present study, we found
that JLDG, as a new AMPK activator, not only inhibited intracellular fat
deposition but also stimulated autophagy in NIT-1 cells. On the one
hand, JLDG could directly enhance the lipolysis by up-regulation of
CPT-1 and inhibit the lipogenesis by down-regulation of SREBP-1C,
ACC and FAS. On the other hand, JLDG could decrease the expression
of mTOR protein and increase the expression of TSC1 and LC3-II
proteins, leading to the enhancement of autophagy. Based on the
concept of lipophagy which connects autophagy and lipid metabolism
the stimulation of autophagy by JLDG might also contribute to the
reduction of fat deposition within β cells. However, these effects of
JLDG can be eliminated in the presence of AMPK inhibitor Compound
C. Collectively, it is obvious that Chinese herbal medicine JLDG, via
AMPK activation, can directly or indirectly attenuate intracellular lipid
overload as discussed above.
However, some limitations of our work should be mentioned.
In the present study, we did not investigate the effect of JLDG on
PA-induced insulin release and apoptosis in NIT-1 cells. Therefore
the effect of JLDG on maintaining β-cell function and mass should
be further conﬁrmed. Actually, some studies take opposing views
on intracellular fat deposition. They even think that the ability of
accumulating triglyceride might be able to protect NIT-1 pancrea-
tic β cells from PA-induced lipotoxicity (Cnop et al., 2001; Choi
et al., 2011) Furthermore, an over stimulated autophagy might also
Fig. 7. The effect of JLDG on the expressions of AMPK downstream antophagy -related genes in NIT-1 pancreatic β cells. JLDG supplementation decreased the expression of
mTOR protein and increased the expression of TSC1 and LC3-II. Representative gels and protein levels for mTOR (A), TSC1 (B) and LC3-II (C), measured by Western blot in
NIT-1 pancreatic β cells from control, model, JLDG, AICAR, Compound C, PIO and Rapa groups. Each bar represents means7SD from three wells. nPo0.05 and nnPo0.01,
signiﬁcantly different from control. ΔPo0.05 and ΔΔPo0.01, signiﬁcantly different from model group. #Po0.05 and ##Po0.01, signiﬁcantly different from JLDG group.
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lead to non-apoptotic cell death (Tsujimoto and Shimizu, 2005).
Hence, more studies are needed in order to explore the mechan-
isms underlying the anti-diabetic effect of JLDG.
5. Conclusion
JLDG containing serum can reduce intracellular lipid accumula-
tion and enhance the autophagy in NIT-1 pancreatic β cells cultured
with PA. The mechanism is possibly mediated by AMPK activation.
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